Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators

被引:47
|
作者
Honorio, KM [1 ]
Garratt, RC [1 ]
Andricopulo, AD [1 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
HQSAR; drug design; nuclear receptors; FXR;
D O I
10.1016/j.bmcl.2005.04.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The farnesoid X receptor (FXR) is an attractive drug target for the development of novel therapeutic agents for the treatment of dyslipidemia and cholestasis. Hologram quantitative structure-activity relationship (HQSAR) studies were conducted on a series of potent FXR activators originated from natural product-like libraries. A training set containing 82 compounds served to establish the models. The best HQSAR model was generated using atoms, bonds, connections, chirality, and donor and acceptor as fragment distinction and fragment size default (4-7) with six components. The model was used to predict the potency of 20 test set compounds that were not included in the training set, and the predicted values were in good agreement with the experimental results. The final HQSAR model and the information obtained from HQSAR 2D contribution maps should be useful for the design of novel FXR ligands having improved potency. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3119 / 3125
页数:7
相关论文
共 50 条
  • [11] Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds
    Campos, JM
    Núñez, MC
    Sánchez, RM
    Gómez-Vidal, JA
    Rodríguez-González, A
    Báñez, M
    Gallo, MA
    Lacal, JC
    Espinosa, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (07) : 2215 - 2231
  • [12] Classical and fragment-based hologram structure-activity relationships for a series of analgesic cyclic imides
    Borchhardt, D. M.
    Castilho, M. S.
    Andricopulo, A. D.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (01) : 57 - 64
  • [13] Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators
    Lum, Robert T.
    Cheng, Mingshan
    Cristobal, Cristina P.
    Goldfine, Ira D.
    Evans, Joseph L.
    Keck, James G.
    Macsata, Robert W.
    Manchem, Vara Prasad
    Matsumoto, Yukiharu
    Park, Sophia J.
    Rao, Sandhya S.
    Robinson, Louise
    Shi, Songyuan
    Spevak, Wayne R.
    Schow, Steven R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6173 - 6187
  • [14] Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors
    Pungpo, P
    Hannongbua, S
    Wolschann, P
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) : 1661 - 1677
  • [15] Predicting toxicity of benzene derivatives by molecular hologram derived quantitative structure-activity relationships (QSARS)
    Cui, S
    Wang, X
    Liu, S
    Wang, L
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2003, 14 (03) : 223 - 231
  • [16] Structure-activity relationships in the acronycine series
    Michel, S
    Seguin, E
    Tillequin, F
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (18) : 1689 - 1700
  • [17] STRUCTURE-ACTIVITY RELATIONSHIPS IN CYPROHEPTADINE SERIES
    ENGELHARDT, EL
    ZELL, HC
    SAARI, WS
    CHRISTY, ME
    COLTON, CD
    JOURNAL OF MEDICINAL CHEMISTRY, 1965, 8 (06) : 829 - +
  • [18] Extending the Structure-Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
    Merk, Daniel
    Lamers, Christina
    Ahmad, Khalil
    Gomez, Roberto Carrasco
    Schneider, Gisbert
    Steinhilber, Dieter
    Schubert-Zsilavecz, Manfred
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) : 8035 - 8055
  • [19] Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists
    Tarzia, G
    Duranti, A
    Tontini, A
    Spadoni, G
    Mor, M
    Rivara, S
    Plazzi, PV
    Kathuria, S
    Piomelli, D
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) : 3965 - 3973
  • [20] Quantitative structure-activity relationships of HIV-1 reverse transcriptase inhibitors, using hologram QSAR
    Pungpo, P
    Wolschann, P
    Hannongbua, S
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 206 - 210